Dr. Laura Bennett PharmD, MPH

BBSW AI Solution Event: Daily Roundup

The BBSW AI Solution event highlighted accelerating AI adoption across pharmaceutical drug discovery, clinical trials, and regulatory submissions, while participants identified critical challenges in data standardization, regulatory validation, and workforce development.

BBSW AI Solution Event: Biotech Innovation in US

The BBSW AI Solution event convened biotech stakeholders to explore artificial intelligence applications in drug discovery, emphasizing the need for rigorous validation, regulatory compliance, and ethical data practices as AI adoption accelerates across the US biotech sector.

BBSW AI Solution Debuts for Pharma Insights

BBSW has launched a new artificial intelligence solution designed to enhance pharmaceutical data analysis and accelerate drug discovery workflows. The platform integrates with existing pharma systems to improve research efficiency and clinical trial optimization.

DIA 2024: Regulatory Insights & Key Sessions to Watch

DIA 2024 offers pharmaceutical regulatory professionals critical updates on FDA policy, real-world evidence integration, and international harmonization. The conference features expert sessions, FDA roundtables, and extensive networking opportunities with regulatory leaders and technology vendors.

DIA 2024: What to Expect in Regulatory Affairs

DIA 2024 will focus on the evolving regulatory landscape, offering discussions on new FDA guidelines and compliance strategies. Networking opportunities with regulatory experts will be available.

DIA 2024: What to Expect at This Year's Event

DIA 2024 offers insights into regulatory updates and industry trends. Networking opportunities and sessions covering clinical trials, data management, and patient engagement will be available.

DIA 2024: What to Expect at the Regulatory Conference

DIA 2024 is a key event for regulatory professionals, offering insights into current regulatory challenges and future directions. The conference provides networking opportunities and sessions on new drug approvals, compliance, and global regulatory harmonization.

Bio-IT World Conference: Oncology Highlights - Day 1

Bio-IT World Conference Day 1 oncology sessions highlighted the transformative role of artificial intelligence, machine learning, and big data analytics in cancer research and precision medicine. Experts discussed advances in genomic data integration, digital pathology, and real-world evidence analytics while addressing critical challenges in data standardization and regulatory compliance.

BioMed Israel 2024: Key Innovations and US Partnerships

BioMed Israel 2024 represents a key opportunity for US pharmaceutical and biotech companies to engage with Israeli innovation in digital health, precision medicine, and therapeutic development. Official conference details remain preliminary; this article provides industry context on US-Israel biotech collaboration trends.

Fierce Biotech Week: Key Takeaways and Emerging Trends

Fierce Biotech Week 2026 convenes industry leaders to address critical challenges in drug development, regulatory strategy, and market access. The event features confirmed keynote speakers, panel discussions, and workshops spanning therapeutic areas including oncology, rare disease, and cell and gene therapy, with flexible in-person, virtual, and hybrid attendance options.

BBSW AI Solution Debuts for Biotech Research in the US

BBSW launches its artificial intelligence platform in the US market to accelerate biotech research efficiency and drug discovery timelines. The solution automates data analysis and pattern recognition while maintaining regulatory compliance and data privacy standards.

BioMed Israel 2026: Top Innovations & US Implications

BioMed Israel 2026 showcased Israeli biotech innovations across digital health, medical devices, and therapeutics, presenting strategic partnership and investment opportunities for US healthcare stakeholders navigating regulatory pathways and market access considerations.

BioMed Israel: Daily Highlights and Key Takeaways

BioMed Israel 2026 is anticipated to serve as a key platform for Israeli biotech innovation and US pharma partnerships, though official details remain pending. This article provides historical context and expected focus areas based on previous conference patterns.

OCT East Coast: Key Takeaways and Highlights

OCT East Coast brings together clinical operations professionals to discuss trial management, regulatory compliance, and operational efficiency. While specific session data remains limited in public sources, the conference addresses key industry challenges shaping the future of clinical trial execution.

ISPOR 2026: Top Cardiology Innovations & Research Highlights

ISPOR 2026 cardiology sessions emphasized the critical role of health economics, real-world evidence, and digital health technologies in shaping cardiovascular drug development and clinical adoption strategies.

US-Japan Healthcare Conf: Key Takeaways for 2026

The 2026 U.S.-Japan Healthcare Conference highlighted expanding bilateral partnerships in regulatory harmonization, digital health innovation, and precision medicine—with particular emphasis on addressing shared demographic challenges and accelerating approval pathways for breakthrough therapies.

COG 2024: Key Highlights and Emerging Trends

NovaPharmaNews cannot publish pharmaceutical coverage of the 2nd Annual COG without verification of the event's actual focus, official agenda, and confirmed clinical data from authoritative sources.

BioNJ BioPartnering Conference: Key Biotech Innovations

The BioNJ BioPartnering Conference brought together biotech executives, pharmaceutical leaders, and venture capitalists to explore strategic partnerships and emerging innovations shaping the life sciences industry.

ASGCT: Key Manufacturing Innovations Day 1

The American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Day 1 focused on critical manufacturing innovations and scalability solutions for cell and gene therapies. Industry leaders discussed process optimization, quality control frameworks, and supply chain strategies essential to advancing CGT commercialization.

ASGCT 2024: Gene Therapy Advancements Day 1 Roundup

ASGCT 2024 convened leading researchers and clinicians to present advances in gene and cell therapy. The conference highlighted emerging therapeutic approaches and underscored growing industry investment in cell and gene therapy platforms.

ISPOR 2026: Cardiology Advances in Cost-Effectiveness Research

ISPOR 2026 highlighted emerging cost-effectiveness frameworks for cardiovascular interventions and emphasized the critical role of real-world evidence in supporting value-based cardiology care and reimbursement decisions.

ASGCT 2024: Day 1 Key Takeaways in Gene Therapy Advancements

ASGCT 2024 Day 1 coverage: This article addresses data gaps in available materials while highlighting what readers should expect from gene and cell therapy presentations, regulatory updates, and manufacturing innovations discussed at the conference.

OCT East Coast: Key Takeaways from Day 1

OCT East Coast Day 1 brought together pharmaceutical and clinical research professionals to discuss operational excellence, regulatory compliance, and collaborative opportunities in clinical trial management. The conference highlighted emerging trends in technology adoption and workforce development within the clinical research sector.

BioMed Israel 2026: Key US Biotech Trends - Day 1 Roundup

BioMed Israel 2026 convened biotech stakeholders on Day 1, though comprehensive coverage of specific company presentations and announcements remains pending official conference materials and press releases.